Page last updated: 2024-09-04

olmesartan and canrenone

olmesartan has been researched along with canrenone in 1 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (canrenone)	Trials (canrenone)	Recent Studies (post-2010) (canrenone)
841	185	554	268	39	59

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ceolotto, G; Cesari, M; Maiolino, G; Rossi, GP; Rossitto, G; Seccia, TM	1

Other Studies

1 other study(ies) available for olmesartan and canrenone

Article	Year
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study. The Journal of clinical endocrinology and metabolism, 2020, 06-01, Volume: 105, Issue:6 Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles	2020

Article

Year

Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.

The Journal of clinical endocrinology and metabolism, 2020, 06-01, Volume: 105, Issue:6

Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Canrenone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Imidazoles; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Prognosis; Prospective Studies; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles

2020